WHITEHOUSE STATION, N.J., June 25, 2011
In A New Post-hoc Analysis, Significantly More Patients Achieved Blood Sugar Goals With JANUMET
Related articles
- Results Of NeuroThera Effectiveness And Safety Trial- 2 (NEST-2) Presented At International Stroke Conference 2009
- Shire Presents Positive Data For Patients With Type 1 Gaucher Disease Who Switched To VPRIV(TM)
- New Data Analysis Supports The Use Of Daxas® (roflumilast) To Further Stabilise Patients Experiencing Frequent COPD Exacerbations
- Data On Mucosal Healing With HUMIRA In Patients With Active Ulcerative Colitis
- Azithromycin Antibiotic Therapy Appears Beneficial In Treatment Of COPD
Comments